Načítá se...
Biodistribution, Tumor Detection, and Radiation Dosimetry of (18)F-5-Fluoro-2′-Deoxycytidine with Tetrahydrouridine in Solid Tumors
In preclinical studies, 5-fluoro-2′-deoxycytidine (FdCyd), an inhibitor of DNA methyltransferase and DNA hypermethylation, has shown treatment efficacy against multiple malignancies by suppressing epigenetic hypermethylation in tumor cells. Several ongoing clinical trials are using FdCyd, and althou...
Uloženo v:
| Vydáno v: | J Nucl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society of Nuclear Medicine
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448462/ https://ncbi.nlm.nih.gov/pubmed/30389817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.216994 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|